证券代码：300008 证券简称：天海防务 公告编号：2025-057 天海融合防务装备技术股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 近日，天海融合防务装备技术股份有限公司（以下简称"天海防务"或"公司"）接到控 股股东厦门隆海重能投资合伙企业（有限合伙）（以下简称"隆海重能"）的通知，隆海重能 将所持有的部分公司股份办理了质押及解除质押手续，具体事项如下： 一、股东股份质押及解除质押基本情况 | 股东名称 | 是否为控 股股东或 | 本次质 | 占其 | 占公 | 是否 | 是否 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 第一大股 | 押数量 | 所持 | 司总 | 为限 | 为补 | 质押起始日 | 质押到期日 | 质权人 | 质押用 | | | 东及其一 | （股） | 股份 | 股本 | 售股 | 充质 | | | | 途 | | | 致行动人 | | 比例 | 比例 | | 押 | | | | | | 隆海重能 ...

证券代码：300008 证券简称：天海防务 公告编号：2025-056 天海融合防务装备技术股份有限公司 关于2022年员工持股计划存续期即将届满的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 天海融合防务装备技术股份有限公司（以下简称"公司"）于 2022 年 10 月 25 日召开了第 五届董事会第二十次会议、第五届监事会第十三次会议，2022 年 11 月 10 日召开了 2022 年第 三次临时股东大会，审议通过了《关于<公司 2022 年员工持股计划>及其摘要的议案》《关于 <公司 2022 年员工持股计划管理办法>的议案》等相关议案，同意公司实施 2022 年员工持股 计划。具体内容详见公司于 2022 年 10 月 26 日、11 月 11 日披露在创业板指定信息披露网站 上的相关公告。 鉴于公司 2022 年员工持股计划（以下简称"本次员工持股计划"）存续期将于 2026 年 1 月 29 日届满，根据《关于上市公司实施员工持股计划试点的指导意见》《深圳证券交易所上 市公司自律监管指引第 2 号——创业板上市公司规范运作》及公司《 ...

从资金流向上来看，当日航海装备板块主力资金净流入1.1亿元，游资资金净流入2342.33万元，散户资 金净流出1.34亿元。航海装备板块个股资金流向见下表： 证券之星消息，7月29日航海装备板块较上一交易日上涨0.62%，国瑞科技领涨。当日上证指数报收于 3609.71，上涨0.33%。深证成指报收于11289.41，上涨0.64%。航海装备板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300600 | 国瑞科技 | 15.70 | 5.94% | 32.83万 | 5.12 乙 | | 601890 | 亚星锚链 | 10.40 | 2.46% | 55.65万 | 5.71亿 | | 300589 | 江龙船艇 | 15.09 | 2.10% | 35.34万 | 5.28亿 | | 300008 | 天海防务 | 7.17 | 1.85% | 190.61万 | 13.61亿 | | 600685 | 中船防务 | 28.20 | 1.73% | 18.42万 | ...

Group 1 - The Terahertz concept sector increased by 2.62%, ranking fifth among concept sectors, with 18 stocks rising, including ShuoBeide which hit a 20% limit up [1] - Leading stocks in the Terahertz sector included Shaanxi Huada, Leike Defense, and Taihao Technology, which rose by 4.92%, 3.85%, and 3.61% respectively [1] - The sector experienced a net inflow of 1.023 billion yuan from main funds, with 11 stocks receiving net inflows, and 5 stocks exceeding 50 million yuan in net inflow [2] Group 2 - ShuoBeide led the net inflow with 833 million yuan, followed by ZTE Communications, Haige Communications, and Tianhai Defense with net inflows of 135 million yuan, 114 million yuan, and 76.79 million yuan respectively [2] - The net inflow ratios for ShuoBeide, Leike Defense, and Haige Communications were 26.89%, 10.30%, and 9.03% respectively [3] - The trading volume and turnover rates for leading stocks in the Terahertz sector were significant, with ShuoBeide showing a turnover rate of 39.04% [3]

Group 1 - Leshan Electric achieved operating revenue of 1.623 billion yuan, a year-on-year increase of 1.94%, and a net profit of 7.9031 million yuan, a year-on-year decrease of 14.55% [1] - Zhimingda reported operating revenue of 295 million yuan, a year-on-year increase of 84.83%, and a net profit of 38.3 million yuan, a year-on-year increase of 2147.93% [2] - Dahu Co. reported operating revenue of 426 million yuan, a year-on-year decrease of 14.40%, and a net loss of 2.5716 million yuan, an improvement from a loss of 13.7824 million yuan in the same period last year [3] - Yubang Electric expects a net profit of 21.2 million to 25 million yuan, a year-on-year decrease of 35.47% to 45.28% [4] - Zhejiang Securities achieved operating revenue of 6.512 billion yuan, a year-on-year decrease of 18.60%, and a net profit of 1.149 billion yuan, a year-on-year increase of 46.54% [5] - Huashu Media reported operating revenue of 4.435 billion yuan, a year-on-year increase of 2.07%, and a net profit of 254 million yuan, a year-on-year increase of 4.63% [7] Group 2 - Sinopec reported oil and gas equivalent production of 262.81 million barrels, a year-on-year increase of 2%, and crude oil processing volume of 119.97 million tons, a year-on-year decrease of 5.3% [8] - Hengrui Medicine's subsidiary received approval for clinical trials of HRS8179, aimed at reducing brain edema after stroke [8] - Hengrui Medicine's subsidiary also received approval for clinical trials of HRS-1893, intended for treating heart failure with preserved ejection fraction [8] - Wanfu Co. announced a plan to reduce its stake by up to 2% through block trading [10] - Biological Co. received a warning letter from the Inner Mongolia Securities Regulatory Bureau for inaccuracies in financial reporting [11] - Zhujiang Co. reported a signed construction area of 47.1432 million square meters across 396 projects [13] Group 3 - Watson Bio received a patent for a peptide delivery system for RNA drugs [15] - Sanwei Chemical signed 31 new contracts worth 335 million yuan in the second quarter [17] - Shenzhou Cell's SCT640C injection received approval for clinical trials for rheumatoid arthritis [18] - Xinjiang Jiaojian reported new contracts worth 1.434 billion yuan in the second quarter [19] - Lais Information plans to use 550 million yuan of idle funds for cash management [21] - Zhongqi New Materials signed a mining rights transfer contract, increasing production capacity [22] Group 4 - Hengtong Optic-Electric won multiple marine energy projects worth 1.509 billion yuan [24] - China State Construction signed new contracts totaling 2.501 trillion yuan in the first half of the year [26] - David Medical's ventilator product registration application has been accepted [28] - Tianhai Defense's subsidiary signed a construction contract worth 16.224 million yuan [29] - Nantian Information plans to sign a procurement framework contract worth 58.27 million yuan with its controlling shareholder [31] - Baida Group announced a plan to reduce its stake by up to 3% [32] Group 5 - Jinli Permanent Magnet plans to issue $117.5 million in convertible bonds [34] - Haizheng Pharmaceutical's fumarate bedaquiline raw material drug application has been approved [36] - Huatai passed the advanced intelligent factory re-evaluation in Anhui Province [37] - Everbright Bank's shareholder increased its stake from 7.08% to 8% [40] - Supor reported total operating revenue of 11.478 billion yuan, a year-on-year increase of 4.68%, and a net profit of 940 million yuan, a year-on-year decrease of 0.07% [41] - Qianjin Pharmaceutical's subsidiaries received registration certificates for two drugs [42]

Group 1 - The company Tianhai Defense (300008) announced that its wholly-owned subsidiary, Shanghai Jiahao Ship Technology Development Co., Ltd., plans to sign multiple contracts with Jiangxi Xinjianzhou Shipbuilding Co., Ltd. for the construction of two 15,000-ton hybrid methanol-electric multi-purpose vessels [1] - The contracts include a project management service contract priced at 4.278 million RMB, a ship design contract priced at 1.86 million RMB, and an equipment procurement contract priced at 10.086 million RMB, totaling 16.224 million RMB [1]

证券代码：300008 证券简称：天海防务 公告编号：2025-054 天海融合防务装备技术股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 天海融合防务装备技术股份有限公司 天海融合防务装备技术股份有限公司（以下简称"公司"）第六届监事会第九次会议于 2025 年 7 月 23 日 11:00 以通讯方式召开，会议通知于 2025 年 7 月 19 日以邮件、微信方式送 达。应参加监事 5 人，实际参加监事 5 人，会议由公司监事会主席黄强先生主持。本次会议举 行与召开符合《公司法》和《公司章程》的有关规定。与会监事经认真审议，形成决议如下： 一、审议通过了《关于签订日常关联交易合同的议案》 经审核，监事会认为：本次全资子公司上海佳豪船舶科技发展公司与江西新江洲船舶重工 有限责任公司签订日常关联交易合同是基于公司生产经营的需要，符合法律法规以及《公司章 程》的有关规定，遵循公开、公平、公正的原则，不存在损害公司及公司股东利益的情况。本 次关联交易事项的审议程序符合相关法律、法规以及规范性文件的规定。因此，同意本次全资 子公司签订日常关联交易合同。 ...

证券代码：300008 证券简称：天海防务 公告编号：2025-055 天海融合防务装备技术股份有限公司 关于签订日常关联交易合同的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、关联交易概述 （一）基本情况 为满足生产经营需要，天海融合防务装备技术股份有限公司（以下简称"公司"）的全资 子公司上海佳豪船舶科技发展公司（以下简称"佳豪科技"）拟与江西新江洲船舶重工有限责 任公司（以下简称"新江洲船舶"或"船厂"）就 2 艘 15000t 级醇电混动多用途船建造项目 （工程号 NJZ1502-NJZ1503，以下简称"本项目"）签订《15000t 级醇电混动多用途船项目管 理服务合同》、《15000t 级醇电混动多用途船船舶设计合同》、《15000t 级醇电混动多用途船 设备采购合同》，上述合同价格分别为 427.8 万元、186 万元、1,008.6 万元，合计为人民币 1,622.40 万元。 佳豪科技将为本项目建造工程的船舶设计审图、船厂招标、相关设备与服务采购、船舶建 造、竣工验收交船直至决算批复提供全程工程项目管理与咨询服务，为本项目提供全部 ...

证券代码：300008 证券简称：天海防务 公告编号：2025-053 天海融合防务装备技术股份有限公司 第六届董事会第十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 天海融合防务装备技术股份有限公司（以下简称"公司"）第六届董事会第十二次会议于 2025 年 7 月 23 日 10:00 以通讯方式召开，会议通知于 2025 年 7 月 19 日以邮件、微信方式送 达。本次会议应参加董事 9 人，实际参加董事 9 人，会议由董事长何旭东先生主持，公司监事、 高管列席了会议。本次会议举行与召开符合《公司法》和《公司章程》的有关规定。与会董事 经认真审议，形成决议如下： 二、备查文件 1、第六届董事会第十二次会议决议； 一、审议通过了《关于签订日常关联交易合同的议案》 2、第六届董事会第六次独立董事专门会议决议。 经会议审议，同意全资子公司上海佳豪船舶科技发展公司与江西新江洲船舶重工有限责任 公司（以下简称"新江洲船舶"）就 2 艘 15000t 级醇电混动多用途船建造项目（工程号 NJZ1502-NJZ1503）签订《15000t 级醇电混 ...

Revenue Situation - In 2024, Tianhai Defense reported the highest revenue in the underwater robotics industry, reaching 3.945 billion yuan, demonstrating strong technical research and market application capabilities [1] - Giant Lifting ranked second with a revenue of 2.214 billion yuan [1] Net Profit Situation - Astar Anchor Chain achieved the highest net profit in 2024, amounting to 335 million yuan [2] - StarNet Yuda reported the lowest net profit, with a loss of 278 million yuan, primarily due to restrictions on military material engineering service procurement qualifications, leading to a significant decrease in order volume and revenue [2] R&D Investment Situation - In 2024, Giant Lifting had the highest R&D investment at 119 million yuan, followed closely by Astar Anchor Chain with 113 million yuan [5] - Tianhai Defense had the lowest R&D investment, totaling 56 million yuan [5] R&D Intensity Situation - Shenhao Technology exhibited the highest R&D intensity, with R&D investment accounting for 67.24% of its revenue [7] - Chip Motion Technology followed with an R&D intensity of 27.07% [7] - Tianhai Defense had the lowest R&D intensity [7] R&D Personnel Situation - Astar Anchor Chain employed the highest number of R&D personnel, totaling 291, which represents 17.80% of the company's total workforce [9] - StarNet Yuda had the highest proportion of R&D personnel relative to its total workforce, at 31.94% [9]